Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review.
about
Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-AnalysisPlacental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting PregnancyManaging lupus patients during pregnancyEndocannabinoids as biomarkers of human reproductionGalectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and NeoplasiaCo-expression network analysis and genetic algorithms for gene prioritization in preeclampsiaDiagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).Integrative data mining to identify novel candidate serum biomarkers for pre-eclampsia screening.Preeclampsia: a bioinformatics approach through protein-protein interaction networks analysis.The importance of early life in childhood obesity and related diseases: a report from the 2014 Gravida Strategic SummitsFLT1 in preeclampsia: trophoblast defense against a decidual VEGFA barrage?Maternal Serum Screening Markers and Adverse Outcome: A New PerspectiveFirst-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics Approach.The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia.Pregnancy Associated Plasma Protein-A and Placental Growth Factor in a Sub-Saharan African Population: A Nested Cross-Sectional Study.Early detection of maternal risk for preeclampsiaFirst trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia.Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspectsWidespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia.Predictive value of miR-210 as a novel biomarker for pre-eclampsia: a systematic review protocol.Development and validation of a prediction model for gestational hypertension in a Ghanaian cohort.Pre-eclampsia part 2: prediction, prevention and management.Pulsatility index in combination with biomarkers or mean arterial pressure for the prediction of pre-eclampsia: Systematic literature review and meta-analysis.Potential role of folate in pre-eclampsia.A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy.Dried blood spot measurement of pregnancy-associated plasma protein A (PAPP-A) and free β-subunit of human chorionic gonadotropin (β-hCG) from a low-resource setting.Absolute first trimester cell-free DNA levels and their associations with adverse pregnancy outcomes.Increased secretory sphingomyelinase activity in the first trimester of pregnancy in women later developing preeclampsia: a nested case-control study.Identification of interleukin-1 beta, but no other inflammatory proteins, as an early onset pre-eclampsia biomarker in first trimester serum by bead-based multiplexed immunoassays.Pre-eclampsia or chronic kidney disease? The flow hypothesis.Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?Prediction of preeclampsia in primigravida in late first trimester using serum placental growth factor alone and by combination model.First trimester uterine artery Doppler, sFlt-1 and PlGF to predict preeclampsia in a high-risk population.First-trimester hyperglycosylated human chorionic gonadotropin and development of hypertension.A prospective study on first trimester prediction of ischemic placental diseases.Placental development and function in women with a history of placenta-related complications: a systematic review.Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers.New Predictive Model at 11+0 to 13+6 Gestational Weeks for Early-Onset Preeclampsia With Fetal Growth Restriction.Two-dimensional sonographic assessment of maximum placental length and thickness in the second trimester: a reproducibility study.
P2860
Q26781355-1193C2E1-DAD3-4CD5-AB99-302EC74C313AQ26861380-C075C467-C841-4338-8390-721E1EE16982Q27002228-0DAD7160-323F-4982-831A-A317866394D0Q27024033-C6269BE9-CF10-4CCF-B56B-0D86213501E1Q28081459-CAFA3200-F439-42C7-92D0-B40787B9BA10Q31143639-BA6B81AC-3EF3-4BF5-B1F9-98064B83B9A7Q33579089-09EA45EC-2234-431F-80FC-CEF47A6E0EB0Q34030774-5F857F32-95E0-4993-8E15-108F7E826C2EQ34370899-D7F63C20-0552-4175-ABE5-C778374E1E96Q34629295-AD81D11C-84BA-4A2E-AA87-D0CCC5EAEE35Q35062407-5B165329-E279-47A9-B1B0-C51245B9E6ADQ35667145-7D0DF614-792C-4BD1-BAED-5A1D87DFF331Q35753391-2C2ADE93-0861-4283-B7A1-D955BCB4C5D4Q36016491-2D085874-584A-4DB7-9B0B-3D7D1631275CQ36105745-B4FA0B06-6E1C-4E42-ADD7-DD5F628C0D69Q36125098-95409E4D-F635-4587-B38A-A88A686C31E1Q36204185-9F6B6E9C-6DD0-44B9-8BD2-71542D1B18E9Q36867367-223A725A-01BC-4AFF-9F76-05138BEB3C5CQ36927599-6B77A31F-8056-4421-94D7-DFFCAAC7961AQ37187628-D7B673C4-C262-4643-A6D5-0659518C2BC0Q37312671-E42861A9-3F22-47DB-83F4-EF56F0BBE497Q37598265-0541FD48-0765-46B3-B8C8-385586C75DBFQ38227251-98B8B947-2C2C-4B26-AEA7-DDD865F76B75Q38543855-AF9E8469-EA28-405D-8931-19B503A9C547Q38584627-8192B7A9-181F-4038-A7F6-2DFFB9B6FE4CQ38824646-28015301-C245-4803-92BD-2A01869785EEQ38923334-EA91BF05-E6D3-4F7F-B1CD-D8A0569A58E7Q40544172-C2A8DAE7-626C-4CB2-BBC1-9294D3583C6AQ40984472-45DA21B3-1470-46CD-8F0B-2C1EED314D3CQ42251202-FA4399B3-3C37-4DB6-A9D5-76AB40BCFB7AQ43838379-ED3269EC-1F44-458C-BDF2-BEE7BFB0552EQ44401617-29E67F00-FC77-4179-9471-A538F3917435Q46304043-ABE24A67-FE3A-4656-8884-2902340D2048Q47804754-A55CAEA3-516A-455A-9D18-9040B43D64CCQ48008304-70BA6ED2-7BCB-4282-BE6A-DFF4880B088CQ48273707-5D8ABAE4-E7DB-42F7-BDAF-4F419242D045Q48325496-CAD31557-1E08-4F01-BF40-15D41DEE1492Q50638104-DE3306BA-7D8E-46DD-8488-044D7DB9C279Q51454988-D065C184-E0E9-4BF5-833E-A0BB0F6E5E7CQ53157848-1B198167-D5EF-4650-B76F-ABF14A92C789
P2860
Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluation of 7 serum biomarke ...... clampsia: a systematic review.
@en
Evaluation of 7 serum biomarke ...... clampsia: a systematic review.
@nl
type
label
Evaluation of 7 serum biomarke ...... clampsia: a systematic review.
@en
Evaluation of 7 serum biomarke ...... clampsia: a systematic review.
@nl
prefLabel
Evaluation of 7 serum biomarke ...... clampsia: a systematic review.
@en
Evaluation of 7 serum biomarke ...... clampsia: a systematic review.
@nl
P2093
P921
P1476
Evaluation of 7 serum biomarke ...... clampsia: a systematic review.
@en
P2093
Arie Franx
Bas B van Rijn
Esther J Wortelboer
Gerard H A Visser
Peter C J I Schielen
Sylwia Kuc
P304
P356
10.1097/OGX.0B013E3182227027
P577
2011-04-01T00:00:00Z